SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-091331
Filing Date
2023-08-14
Accepted
2023-08-14 16:10:40
Documents
2
Period of Report
2023-08-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2323677-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2323677-1_4seq1.xml 4 3761
2 EXHIBIT 24 tm2323677d1_ex24.htm EX-24 6342
  Complete submission text file 0001104659-23-091331.txt   11613
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Issuer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DONG-A ST & DONG-A SOCIO GROUP 64 CHEONHO DAERO, DONGDAEMUN-GU SEOUL M5 00000
Business Address
Kim Hyung Heon (Reporting) CIK: 0001873258 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37809 | Film No.: 231170159